A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/240
A61K 31/40 (2006.01) A61K 31/405 (2006.01)
Patent
CA 2038409
PC7755GCB USE OF TENIDAP TO INHIBIT ACTIVATION OF COLLAGENASE AND TO INHIBIT THE ACTIVITY OF MYELOPEROXIDASE Abstract This invention relates to the use of tenidap, 5-chloro-2,3-dihydro-2-oxo-3-(2-thienylcarbonyl)- indole-1-carboxamide, and the pharmaceutically- acceptable base salts thereof to inhibit activation of collagenase in a mammal and to inhibit the activity of myeloperoxidase in a mammal. This invention also relates to the use of tenidap and its salts for treating collagenase mediated disorders and diseases such as bone resorption disorders, corneal ulceration, periodontal disease, inflammatory disease and wounds of the skin and burns in mammals. The methods of this invention comprise administering an effective amount of tenidap or salts thereof to a mammal.
Blackburn Warren Darrel Jr.
Loose Leland David
Limited Pfizer
Smart & Biggar
LandOfFree
Use of tenidap to inhibit activation of collagenase and to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tenidap to inhibit activation of collagenase and to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tenidap to inhibit activation of collagenase and to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1670476